source
- STAT+: Biotech raises $42 million to run Huntington’s disease trialLatus Bio raised $42 million as it prepares to seek FDA approval to start a clinical trial for its gene therapy for Huntington's disease.STAT · 2mo ago↗ source
- Immigration changes are driving foreign researchers to leave the U.S. — or not come to begin withLabs are seeing fewer applications from international students and researchers, and some doctoral students are considering leaving early.STAT · 2mo ago↗ source
- Opinion: Are blue zones real? Answering that question is harder than ever"Blue zones" as a concept have strayed far and wide from their humble roots, write Shelley Wood and Eric Topol.STAT · 2mo ago↗ source